We have found 46587 results matching your criteria.
Please wait while we search...

General Material Information

Preferred name bergamot oil
Trivial Name Bergamot oil
Short Description volatile oil obtained from the peel of citrus aurantium bergamia, rutaceae
CAS Number 8007-75-8
FEMA Number 2153
ECHA Number 296-429-8
FDA UNII 39W1PKE3JI
COE Number 137
FDA Patent No longer provide for the use of these seven synthetic flavoring substances
FDA Mainterm 8007-75-8 ; BERGAMOT, OIL (CITRUS AURANTIUM L. SUBSP. BERGAMIA WRIGHT ET ARN.)
Synonyms
  • bergamot oil organic
  • bergamot oil rectified
  • bergamot oil, argentina
  • bergamote ess TBM 01
  • bergamote ess TBM 02
  • bergamote select 01
  • citrus aurantium bergamia peel oil
  • citrus aurantium var. bergamia peel oil
  • citrus bergamia peel oil
  • citrus x bergamia peel oil
  • volatile oil obtained from the peel of citrus aurantium bergamia, rutaceae
  • citrus × bergamia peel oil
  • Oils, bergamot
  • Essential oils, bergamot
  • Oils, essential, bergamot
  • Bergamot peel oil
  • Oils, bergamot peel
  • Citrus bergamia oil
  • Oil of bergamot
  • Bergamot essential oil
  • Essential oils, Citrus bergamia

US / EU / FDA / JECFA / FEMA / Scholar / Patents

Google Scholar Start search
Google Books Start search
Google Patents Start search
Perfumer & Flavorists Start search
EU Patents Start search
PubMeb Start search
NCBI Start search

Literature & References

citrus × bergamia peel oil
Canada Domestic Sub. List:8007-75-8
Pubchem (sid):135289949
Publications by PubMed
Flavonoid Fraction of Bergamot Juice Reduces LPS-Induced Inflammatory Response through SIRT1-Mediated NF-κB Inhibition in THP-1 Monocytes.
Bergamot Juice Extract Inhibits Proliferation by Inducing Apoptosis in Human Colon Cancer Cells.
Antibacterial activity of essential oils, their blends and mixtures of their main constituents against some strains supporting livestock mastitis.
Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models.
Magnetically recoverable, thermostable, hydrophobic DNA/silica encapsulates and their application as invisible oil tags.
The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes.
Citrus bergamia Risso Elevates Intracellular Ca (2+) in Human Vascular Endothelial Cells due to Release of Ca (2+) from Primary Intracellular Stores.
Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells.
Inhibitory effect of essential oils against Trichosporon ovoides causing Piedra Hair Infection.
Ultra high performance liquid chromatography with ion-trap TOF-MS for the fast characterization of flavonoids in Citrus bergamia juice.
Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells.
Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juice.
The essential oil of Citrus bergamia Risso induces vasorelaxation of the mouse aorta by activating K(+) channels and inhibiting Ca(2+) influx.
Bergamot essential oil differentially modulates intracellular Ca2+ levels in vascular endothelial and smooth muscle cells: a new finding seen with fura-2.
Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation.
N-methylated tryptamine derivatives in citrus genus plants: identification of N,N,N-trimethyltryptamine in bergamot.
The anti-biofilm activity of lemongrass (Cymbopogon flexuosus) and grapefruit (Citrus paradisi) essential oils against five strains of Staphylococcus aureus.
Fungal decay and shelf life of oranges coated with chitosan and bergamot, thyme, and tea tree essential oils.
Protective effects of an extract from Citrus bergamia against inflammatory injury in interferon-γ and histamine exposed human keratinocytes.
In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components.
Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial.
Occurrence of pipecolic acid and pipecolic acid betaine (homostachydrine) in Citrus genus plants.
Aroma-therapeutic effects of massage blended essential oils on humans.
Toxic profile of bergamot essential oil on survival and proliferation of SH-SY5Y neuroblastoma cells.
Betaines in fruits of Citrus genus plants.
Citrus bergamia juice: phytochemical and technological studies.
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines.
Update of the toxicological assessment of furanocoumarins in foodstuffs (Update of the SKLM statement of 23/24 September 2004)--Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG).
Antiviral activity of seed extract from Citrus bergamia towards human retroviruses.
Proline derivatives in fruits of bergamot (Citrus bergamia Risso et Poit): presence of N-methyl-L-proline and 4-hydroxy-L-prolinebetaine.
Acute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats.
Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism.
In vitro photo-induced cytotoxic activity of Citrus bergamia and C. medica L. cv. Diamante peel essential oils and identified active coumarins.
In vitro protective effects of two extracts from bergamot peels on human endothelial cells exposed to tumor necrosis factor-alpha (TNF-alpha).
Antioxidant/lipoxygenase inhibitory activities and chemical compositions of selected essential oils.
Selective removal of monoterpenes from bergamot oil by inclusion in deoxycholic acid.
In vitro inhibition of vancomycin-susceptible and vancomycin-resistant Enterococcus faecium and E. faecalis in the presence of citrus essential oils.
Neuropharmacology of the essential oil of bergamot.
New asymmetrical per-substituted cyclodextrins (2-O-methyl-3-O-ethyl- and 2-O-ethyl-3-O-methyl-6-O-t-butyldimethylsilyl-beta-derivatives) as chiral selectors for enantioselective gas chromatography in the flavour and fragrance field.
Effects of systemic administration of the essential oil of bergamot (BEO) on gross behaviour and EEG power spectra recorded from the rat hippocampus and cerebral cortex.
Effects of music and essential oil inhalation on cardiac autonomic balance in healthy individuals.
Citrus bergamia Risso & Poiteau juice protects against renal injury of diet-induced hypercholesterolemia in rats.
Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat.
Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors.
Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides.
[The effects of aromatherapy on stress and stress responses in adolescents].
Bergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.
High quality bergamot oil from Greece: Chemical analysis using chiral gas chromatography and larvicidal activity against the West Nile virus vector.
The mechanism of action of a citrus oil blend against Enterococcus faecium and Enterococcus faecalis.
Evaluation of flavonoids and furanocoumarins from Citrus bergamia (Bergamot) juice and identification of new compounds.
[Effects of aroma hand massage on pain, state anxiety and depression in hospice patients with terminal cancer].
Estimating bergamot juice adulteration of lemon juice by high-performance liquid chromatography (HPLC) analysis of flavanone glycosides.
The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation.
Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry.
Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet.
Further insights into the floral character of Touriga Nacional wines.
UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis.
Distribution of flavonoids and furocoumarins in juices from cultivars of Citrus bergamia Risso.
Comparison of the volatile constituents in cold-pressed bergamot oil and a volatile oil isolated by vacuum distillation.
Phototoxicity of bergamot oil assessed by in vitro techniques in combination with human patch tests.
[Purely natural: phototoxic dermatitis].
Evaluation of phototoxic properties of fragrances.
The survival of three strains of Arcobacter butzleri in the presence of lemon, orange and bergamot essential oils and their components in vitro and on food.
Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro.
[The effects of the inhalation method using essential oils on blood pressure and stress responses of clients with essential hypertension].
The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons.
In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
The effect of lemon, orange and bergamot essential oils and their components on the survival of Campylobacter jejuni, Escherichia coli O157, Listeria monocytogenes, Bacillus cereus and Staphylococcus aureus in vitro and in food systems.
Enzymatic hydrolysis of flavonoids and pectic oligosaccharides from bergamot (Citrus bergamia Risso) peel.
Mosquito larvicidal activity of aromatic medicinal plant oils against Aedes aegypti and Culex pipiens pallens.
Flavonoid glycosides in bergamot juice (Citrus bergamia Risso).
[Toxic mustard plaster dematitis and phototoxic dematitis after application of bergamot oil].
Characterization of flavonoids and pectins from bergamot (Citrus bergamia Risso) peel, a major byproduct of essential oil extraction.
High-throughput analysis of bergamot essential oil by fast solid-phase microextraction-capillary gas chromatography-flame ionization detection.
Assessment of the phototoxic hazard of some essential oils using modified 3T3 neutral red uptake assay.
Determination of some heavy metals and selenium in Sicilian and Calabrian citrus essential oils using derivative stripping chronopotentiometry.
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Combination of supercritical CO2 and vacuum distillation for the fractionation of bergamot oil.
Pesticide and plasticizer residues in bergamot essential oils from Calabria (Italy).
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice.
Chemical and biological diversity of Bergamot (Citrus bergamia) in relation to environmental factors.
Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial.
Rodenticidal activity of two natural coumarines from ether extract of Citrus bergamia.
Effects of rootstock on the composition of bergamot (Citrus bergamia Risso et Poiteau) essential oil.
Determination of 5-methoxypsoralen in human serum.
Earl Grey, in excess.
Analysis of limette and bergamot distilled essential oils by HPLC.
Toxic effects of six plant oils alone and in combination with controlled atmosphere on Liposcelis bostrychophila (Psocoptera: Liposcelididae).
Accidental bullous phototoxic reactions to bergamot aromatherapy oil.
How big is a drop? A volumetric assay of essential oils.
Dangers of the intake of psoralens and subsequent UV exposure producing significant burns.
Quantitative assessment of epidermal melanogenesis in C3H/Tif hr/hr mice treated with topical furocoumarins and UVA radiation.
Action spectrum for bergamot-oil phototoxicity measured by sunburn cell counting.
Evaluation of phototoxic and photogenotoxic risk associated with the use of photosensitizers in suntan preparations: application to tanning preparations containing bergamot oil.
Studies on the genotoxic properties of essential oils with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay.
High-performance liquid chromatographic determination of citropten and bergapten in suction blister fluid after solar product application in humans.
Photoreactivity of 5-geranoxypsoralen and lack of photoreaction with DNA.
Citropten and bergapten suction blister fluid concentrations after solar product application in man.
The photochemistry and photobiology of bergamot oil as a perfume ingredient: an overview.
Phototoxic properties of perfumes containing bergamot oil on human skin: photoprotective effect of UVA and UVB sunscreens.
Phototumorigenesis studies of 5-methoxypsoralen in bergamot oil: evaluation and modification of risk of human use in an albino mouse skin model.
Genotoxicity of bergapten and bergamot oil in Saccharomyces cerevisiae.
In vitro photostability and photosensitizing properties of bergamot oil. Effects of a cinnamate sunscreen.
A quantitative in vitro assay for the evaluation of phototoxic potential of topically applied materials.
Phytophotodermatitis.
[Contact dermatitis caused by bergamot oil].
Inhibition of bergaptene toxicity by UV-A filters.
[Phototoxicity of Bergamot oil. Comparison between humans and guinea pigs].
A study of oil of bergamot and its importance as a phototoxic agent. II. Factors which affect the phototoxic reaction induced by bergamot oil and psoralen derivatives.
[Accidents due to tanning cosmetics with a base of bergamot oil].
[The zinc oxide and bergamot oil gingival dressing and rationale of its preparation].
[Simplified method of preparation of the zinc oxide-bergamot oil gingival dressing].
[EXPERIMENTAL STUDY OF GINGIVAL DRESSING WITH BERGAMOT OIL].
[Chemical composition of the endocarpus of the fruit of bergamot (Citrus bergamia, Risso)].
[Vitamin content of bergamot].
[Not Available].
Local sensitization of the skin to Grenz rays by bergamot oil.

Other Information

FDA Substances Added to Food (formerly EAFUS):View
Export Tariff Code:3301.11.0000
Typical G.C.
Wikipedia:View
FAO:BASIC PRINCIPLES OF STEAM DISTILLATION

PhysChem Properties

Material listed in food chemical codex Yes
Specific gravity @ 25 °C
Pounds per Gallon 7.289 to 7.356
Refractive Index 1.464 to 1.466 @ 20 °C
Flash Point TCC Value 42.22 °C TCC
Solubility
alcohol Yes
fixed oils Yes
water, 20.12 mg/L @ 25 °C (est) Yes
water No
glycerin No
propylene glycol No
Stability
non-discoloring in most media Unspecified

Organoleptic Properties

Odor Type: Citrus
citrus, floral, green, spicy, orange peel, ginger
General comment At 100.00 %. citrus woody orange linalyl acetate
Flavor Type: Citrus
citrus, floral, rose, green, lemon
General comment Bergamot

Occurrences

Safety Information

Safety information

European information :
Most important hazard(s):
Xi - Irritant
R 10 - Flammable.
R 36/37/38 - Irritating to eyes, respiratory system, and skin.
R 43 - May cause sensitisation by skin contact.
S 02 - Keep out of the reach of children.
S 16 - Keep away from sources of ignition - No Smoking.
S 24/25 - Avoid contact with skin and eyes.
S 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S 36 - Wear suitable protective clothing.
Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Pictogram
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
oral-rat LD50 11520 mg/kg
Pharmazie. Vol. 14, Pg. 435, 1959.

Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined

Safety in use information

Category:
flavor and fragrance agents
RIFM Fragrance Material Safety Assessment: Search
IFRA Code of Practice Notification of the 49th Amendment to the IFRA Code of Practice
IFRA Critical Effect:
Phototoxicity
IFRA fragrance material specification:
Where the bergapten (5-methoxypsoralen) content of all relevant oils present in a compound has been determined, it is recommended that for applications on areas of skin exposed to sunshine, excluding bath preparations, soaps and other products which are washed off the skin, the total level of bergapten in the consumer products should not exceed 0.0015% (15 ppm). This is equivalent to 0.0075% (75 ppm) in a fragrance compound used at 20% in the consumer product. Where the level of bergapten has not been determined by appropriate methods, the limits specified in the guidelines on individual oils should apply. In those cases, where such oils are used in combination with other phototoxic ingredients, the additive effect has to be taken into consideration and the use levels have to be reduced accordingly. The sum of the concentrations of all phototoxic fragrance ingredients, expressed in % of their recommended maximum level in the consumer product, shall not exceed 100. exceed 0.0015% (15 ppm). This is equivalent to 0.0075% (75 ppm) in a fragrance compound used at 20% in the consumer product. Where the level of bergapten has not been determined by appropriate methods, the limits specified in the guidelines on individual oils should apply. In those cases, where such oils are used in combination with other phototoxic ingredients, the additive effect has to be taken into consideration and the use levels have to be reduced accordingly. The sum of the concentrations of all phototoxic fragrance ingredients, expressed in % of their recommended maximum level in the consumer product, shall not exceed 100.
contains the following IFRA (Annex) restricted components: (non-analysis max. level reference only)
citral Max. Found: 0.7 % and Reason: Sensitization
geraniol Max. Found: 0.1 % and Reason: Sensitization
7-methoxycoumarin Max. Found: 0.01 % and Reason: Sensitization, photosensitization
View the IFRA Standard
View IFRA Standards Library for complete information.
Please review Amendment 49 IFRA documentation for complete information.
IFRA RESTRICTION LIMITS IN THE FINISHED PRODUCT (%):
Category 1: Products applied to the lips
0.40 %
Category 2: Products applied to the axillae
0.40 %
Category 3: Products applied to the face/body using fingertips
0.40 %
Category 4: Products related to fine fragrance
0.40 %
Category 5: Products applied to the face and body using the hands (palms), primarily leave-on
Category 5A: Body lotion products applied to the body using the hands (palms), primarily leave-on
0.40 %
Category 5B: Face moisturizer products applied to the face using the hands (palms), primarily leave-on
0.40 %
Category 5C: Hand cream products applied to the hands using the hands (palms), primarily leave-on
0.40 %
Category 5D: Baby Creams, baby Oils and baby talc
0.40 %
Category 6: Products with oral and lip exposure
0.40 %
Category 7: Products applied to the hair with some hand contact
Category 7A: Rinse-off products applied to the hair with some hand contact
No Restriction %
Category 7B: Leave-on products applied to the hair with some hand contact
0.40 %
Category 8: Products with significant anogenital exposure
0.40 %
Category 9: Products with body and hand exposure, primarily rinse off
No Restriction %
Category 10: Household care products with mostly hand contact
Category 10A: Household care excluding aerosol products (excluding aerosol/spray products)
No Restriction %
Category 10B: Household aerosol/spray products
0.40 %
Category 11: Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate
Category 11A: Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
No Restriction %
Category 11B: Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
0.40 %
Category 12: Products not intended for direct skin contact, minimal or insignificant transfer to skin
No Restriction
Notes:
IFRA FLAVOR REQUIREMENTS:

Due to the possible ingestion of small amounts of fragrance ingredients from their use in products in Categories 1 and 6, materials must not only comply with IFRA Standards but must also be recognized as safe as a flavoring ingredient as defined by the IOFI Code of Practice (www.iofi.org). For more details see chapter 1 of the Guidance for the use of IFRA Standards.

Use levels for FEMA GRAS flavoring substances on which the FEMA Expert Panel based its judgments that the substances are generally recognized as safe (GRAS).
The Expert Panel also publishes separate extensive reviews of scientific information on all FEMA GRAS flavoring substances and can be found at FEMA Flavor Ingredient Library
publication number: 3
Click here to view publication 3
average usual ppmaverage maximum ppm
baked goods: -29.00000
beverages(nonalcoholic): -8.90000
beverages(alcoholic): --
breakfast cereal: --
cheese: --
chewing gum: -43.00000
condiments / relishes: --
confectionery froastings: 1.00000130.00000
egg products: --
fats / oils: --
fish products: --
frozen dairy: -7.90000
fruit ices: -7.90000
gelatins / puddings: 5.3000090.00000
granulated sugar: --
gravies: --
hard candy: -27.00000
imitation dairy: --
instant coffee / tea: --
jams / jellies: --
meat products: --
milk products: --
nut products: --
other grains: --
poultry: --
processed fruits: --
processed vegetables: --
reconstituted vegetables: --
seasonings / flavors: --
snack foods: --
soft candy: --
soups: --
sugar substitutes: --
sweet sauces: --

Safety references

EPI System: View
Daily Med:search
Chemical Carcinogenesis Research Information System:Search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):8007-75-8
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
National Institute of Allergy and Infectious Diseases:Data
WISER:UN 1993
WGK Germany:2
citrus × bergamia peel oil
Chemidplus:0008007758
RTECS:DS0500000 for cas# 8007-75-8